INVESTMENT IN MARKETABLE SECURITIES (Tables)

3 Months Ended

Oct. 31, 2020

Investment In Marketable Securities

Schedule of Investment in Marketable Securities

Unrealized gains and losses on these securities are included in operations for the applicable period.

							Change in
							Fair Value
							For the
	Number						Three Months
	of		Fair Value at				Ended
	Shares		July 31, 2020		October 31, 2020		October 31, 2020
Common Shares of Entest Group, Inc. (ENTI)		66,667	$	260	$	526	$	267
Common Shares of Regen Biopharma, Inc. (RGBP)		29,076,665		5,814		11,630		5,815
Series A Preferred Shares of Regen Biopharma, Inc. (RGBPP)		2,907,666		4,362		4,362		-
Total			$	10,436	$	16,518	$	6,082